SE8700527D0 - BENZOHETEROCYCLIC COMPOUNDS - Google Patents

BENZOHETEROCYCLIC COMPOUNDS

Info

Publication number
SE8700527D0
SE8700527D0 SE8700527A SE8700527A SE8700527D0 SE 8700527 D0 SE8700527 D0 SE 8700527D0 SE 8700527 A SE8700527 A SE 8700527A SE 8700527 A SE8700527 A SE 8700527A SE 8700527 D0 SE8700527 D0 SE 8700527D0
Authority
SE
Sweden
Prior art keywords
substd
thiomorpholino
halogen
opt
methyl
Prior art date
Application number
SE8700527A
Other languages
Swedish (sv)
Other versions
SE501371C2 (en
SE8700527L (en
Inventor
H Ueda
H Miyamoto
S Aki
T Otsuka
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of SE8700527D0 publication Critical patent/SE8700527D0/en
Publication of SE8700527L publication Critical patent/SE8700527L/en
Publication of SE501371C2 publication Critical patent/SE501371C2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Abstract

(+8.5.86, 22.5.86, 23.7.86, 19.8.86, 30.9.86, 15.10.86, 18.12.86-JP-105655, 118568, 173370, 193838, 233837, 246050, 303515) (1703KM) - 4-Oxoquinoline-3-carboxylic acid cpds. of formula (I) and their salts are new. R1 is cyclopropyl opt. substd. by 1-3 substits. selected from lower alkyl and halogen; R2 is 5-9 membered opt. unsatd. heterocyclic ring which may be substd. R3 is lower alkyl which may be substd. by 1-3 substits. selected from a 5- or 6-membered satd. heterocyclic ring, lower alkylthio, amino, lower-alkylamino, lower alkanoyloxy, OH, lower alkoxy and halogen; and X is halogen. - Pref. R2 is opt. substd. 1-piperidinyl, 1-pyrrolidinyl, 1-homopiperazinyl, thiomorpholino, 1,4-diazabicyclo (4.3.0) nona-4-yl, thiomorpholino-4-oxide, thiomorpholino-4,4-dioxide, 1-hexahydropyridazinyl, 2-thiazolidinyl, 1-imidazolidinyl or 3,7-diazabicyclo (4.3.0) nona-3-yl. - 10 Cpds. of (I) including 7-(4-(5-methyl) 2-oxo-1,3-dioxolen -4-yl) methyl-1-piperazinyl) -1-cyclopropyl-6-fluoro- 8-methyl-1,4-dihydro-4-oxoquinoline -3-carboxylic acid are described.
SE8700527A 1986-02-25 1987-02-11 New 4-oxo:quinoline-3-carboxylic acid cpds. - having antimicrobial activity against Gram positive and Gram negative bacteria and other microorganisms SE501371C2 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP4092186 1986-02-25
JP10565586 1986-05-08
JP11856886 1986-05-22
JP17337086 1986-07-23
JP19383886 1986-08-19
JP23383786 1986-09-30
JP24605086 1986-10-15
JP30351586 1986-12-18

Publications (3)

Publication Number Publication Date
SE8700527D0 true SE8700527D0 (en) 1987-02-11
SE8700527L SE8700527L (en) 1987-08-26
SE501371C2 SE501371C2 (en) 1995-01-23

Family

ID=27572272

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8700527A SE501371C2 (en) 1986-02-25 1987-02-11 New 4-oxo:quinoline-3-carboxylic acid cpds. - having antimicrobial activity against Gram positive and Gram negative bacteria and other microorganisms

Country Status (2)

Country Link
KR (1) KR970000950B1 (en)
SE (1) SE501371C2 (en)

Also Published As

Publication number Publication date
SE501371C2 (en) 1995-01-23
KR870007912A (en) 1987-09-22
KR970000950B1 (en) 1997-01-21
SE8700527L (en) 1987-08-26

Similar Documents

Publication Publication Date Title
DE3878833D1 (en) THIENO (TRIAZOLO) DIAZEPINE COMPOUNDS, AND MEDICAL USE THEREOF.
ES2060585T3 (en) 1,2,3,3A, 8,8A-HEXAHIDRO-1,3A, 8-TRIMETILPIRROLO (2,3-B) INDOLES, A PROCEDURE FOR THEIR PREPARATION AND USE AS MEDICINES.
DK633088D0 (en) HIS UNKNOWN RELATIONSHIPS
CA1272482C (en) Quinolinecarboxylic acid derivatives
ES8801188A1 (en) Heterocyclic compounds, their production, and medicaments containing them.
SE7710873L (en) NEW 1H-PYRAZOLO (3,4-B) PYRIDINES
PH16815A (en) 5-(heterocyclic amino-propiionyl)-5,10-dihydro-11h-dibenzo(b,e)(1,4)diazepin-11-ones
SE8700527D0 (en) BENZOHETEROCYCLIC COMPOUNDS
DK160308C (en) ANALOGY PROCEDURE FOR PREPARING 1,2,4-TRIAZOLO (4,3-A) QUINAZOLIN-5- (4H) -ONES OR THEIR ACID ADDITION SALTS
NO885549D0 (en) PROCEDURE FOR THE PREPARATION OF AMID DERIVATIVES.
IT1224225B (en) New 4-oxo:quinoline-3-carboxylic acid cpds.
ES2004243A6 (en) New 4-oxo:quinoline-3-carboxylic acid cpds. - having antimicrobial activity against Gram positive and Gram negative bacteria and other microorganisms
ES8601952A1 (en) 5-(4-Chloro-3-sulfamoylbenzoyl)-2,3-dihydro-2-benzofuran-carboxylic acids and process for their preparation.
DE3782034D1 (en) OXA (THIA) ZOLIDINE DERIVATIVES.
DE3750842D1 (en) Penem derivatives, their production and use.
EP0298134A4 (en) Aromatic heterocyclic carboxylic acid amide derivatives, process for their preparation, and pharmaceutical composition containing same.
FI851308A0 (en) FORMULATION OF FRAMSTAELLNING AV NYA 1,2,4-THIADIAZINE.
FI861001A (en) BENZO / C / -1,5-NAFTYRIDINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH I DERAS FRAMSTAELLNING ANVAENDBARA MELLANPRODUKTER SAMT DERAS ANVAENDNING SAOSOM LAEKEMEDEL.
SE8801907D0 (en) NOVEL PHARMACOLOGICAL COMPOUNDS
SE8302411L (en) CONDENSED CYCLOALIFATIC DERIVATIVES OF SUBSTITUTED PYRIDO (1,2-A) PYRIMIDINES
FI872797A (en) SUBSTITUERADE KINOXALINDIONER OCH KINOLINDIONER.
DE3777999D1 (en) SUBSTITUTED PIPERIDINE OR AZEPINE, THEIR PRODUCTION AND THERAPEUTIC USE.
DK624086D0 (en) 6H-ISOXAZOLO (3,4-D) PYRAZOLO (3,4-B) PYRIDINES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS THEREOF, THEIR PREPARATION AND USE AS ANXIOLYTICS